Antibiotic-Resistant Neisseria gonorrhoeae Spread Faster with More Treatment, Not More Sexual Partners

The sexually transmitted bacterium Neisseria gonorrhoeae has developed resistance to all antibiotic classes that have been used for treatment and strains resistant to multiple antibiotic classes have evolved. In many countries, there is only one antibiotic remaining for empirical N. gonorrhoeae treatment, and antibiotic management to counteract resistance spread is urgently needed. Understanding dynamics and drivers of resistance spread can provide an improved rationale for antibiotic management. In our study, we first used antibiotic resistance surveillance data to estimate the rates at which antibiotic-resistant N. gonorrhoeae spread in two host populations, heterosexual men (HetM) and men who have sex with men (MSM). We found higher rates of spread for MSM (0.86 to 2.38 y−1, mean doubling time: 6 months) compared to HetM (0.24 to 0.86 y−1, mean doubling time: 16 months). We then developed a dynamic transmission model to reproduce the observed dynamics of N. gonorrhoeae transmission in populations of heterosexual men and women (HMW) and MSM. We parameterized the model using sexual behavior data and calibrated it to N. gonorrhoeae prevalence and incidence data. In the model, antibiotic-resistant N. gonorrhoeae spread with a median rate of 0.88 y−1 in HMW and 3.12 y−1 in MSM. These rates correspond to median doubling times of 9 (HMW) and 3 (MSM) months. Assuming no fitness costs, the model shows the difference in the host population’s treatment rate rather than the difference in the number of sexual partners explains the differential spread of resistance. As higher treatment rates result in faster spread of antibiotic resistance, treatment recommendations for N. gonorrhoeae should carefully balance prevention of infection and avoidance of resistance spread.

[1]  D. Campos-Outcalt.  CDC update on gonorrhea: expand treatment to limit resistance. , 2011, The Journal of family practice.

[2]  J. Yorke,et al.  Gonorrhea Transmission Dynamics and Control , 1984 .

[3]  J. Wadsworth,et al.  Estimating the sexual mixing patterns in the general population from those in people acquiring gonorrhoea infection: theoretical foundation and empirical findings. , 1995, Journal of epidemiology and community health.

[4]  R M Anderson,et al.  Gonococcal infection, infertility, and population growth: II. The influence of heterogeneity in sexual behaviour. , 1992, IMA journal of mathematics applied in medicine and biology.

[5]  D. Livermore,et al.  Annual Report of the Chief Medical Officer: infection and the rise of antimicrobial resistance , 2013, The Lancet.

[6]  J M Kaldor,et al.  Incidence and risk factors for urethral and anal gonorrhoea and chlamydia in a cohort of HIV-negative homosexual men: the Health in Men Study , 2006, Sexually Transmitted Infections.

[7]  D. Livermore,et al.  Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011. , 2013, The Lancet. Infectious diseases.

[8]  J. Zenilman,et al.  Genetic Typing of the Porin Protein of Neisseria gonorrhoeae from Clinical Noncultured Samples for Strain Characterization and Identification of Mixed Gonococcal Infections , 2005, Journal of Clinical Microbiology.

[9]  W. Shafer,et al.  Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations. , 2012, Journal of Infectious Diseases.

[10]  S Bonhoeffer,et al.  Evaluating treatment protocols to prevent antibiotic resistance. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  G. V. van Doornum,et al.  Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by ligase chain reaction-based assays with clinical specimens from various sites: implications for diagnostic testing and screening , 1996, Journal of clinical microbiology.

[12]  I Lind,et al.  Antimicrobial resistance in Neisseria gonorrhoeae. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Douglas M. Warner,et al.  Regulation of the MtrC-MtrD-MtrE efflux-pump system modulates the in vivo fitness of Neisseria gonorrhoeae. , 2007, The Journal of infectious diseases.

[14]  S. McGuire,et al.  Centers for Disease Control and Prevention. State indicator report on Physical Activity, 2014. Atlanta, GA: U.S. Department of Health and Human Services; 2014. , 2014, Advances in nutrition.

[15]  Elizabeth A Torrone,et al.  Sexually transmitted disease surveillance 2013 , 2014 .

[16]  N. Low,et al.  Individual and Population Level Effects of Partner Notification for Chlamydia trachomatis , 2011, Sexually Transmitted Infections.

[17]  K. Soetaert.  Nonlinear Root Finding, Equilibrium and Steady-State Analysis ofOrdinary Differential Equations , 2015 .

[18]  W John Edmunds,et al.  A metapopulation modelling framework for gonorrhoea and other sexually transmitted infections in heterosexual populations , 2009, Journal of The Royal Society Interface.

[19]  Peter Dalgaard,et al.  R Development Core Team (2010): R: A language and environment for statistical computing , 2010 .

[20]  W. Levine,et al.  The transmission dynamics of gonorrhoea: modelling the reported behaviour of infected patients from Newark, New Jersey. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[21]  J. Tapsall,et al.  Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the World Health Organization Western Pacific Region, 2003. , 2005, Communicable diseases intelligence quarterly report.

[22]  Marc Choisy,et al.  P08.34 Number of sex acts matters for heterosexual transmission and control of chlamydia trachomatis , 2015 .

[23]  G. Hughes.  Changing Trends in Decreased Susceptibility of Neisseria Gonorrhoeae to Cephalosporins in England and Wales: 2012 Data from the National Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) , 2014 .

[24]  Robert E. Johnson,et al.  Gonorrhea and Chlamydia in the United States among Persons 14 to 39 Years of Age, 1999 to 2002 , 2007, Annals of Internal Medicine.

[25]  M. Unemo,et al.  2012 European guideline on the diagnosis and treatment of gonorrhoea in adults , 2013, International journal of STD & AIDS.

[26]  Marc Lipsitch,et al.  Improving Control of Antibiotic-Resistant Gonorrhea by Integrating Research Agendas Across Disciplines: Key Questions Arising From Mathematical Modeling. , 2016, The Journal of infectious diseases.

[27]  J. Papp,et al.  The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  V. Rich.  Personal communication , 1989, Nature.

[29]  J. Yorke,et al.  Dynamics and Control of the Transmission of Gonorrhea , 1978, Sexually transmitted diseases.

[30]  R. Guy,et al.  Exploring the Benefits of Molecular Testing for Gonorrhoea Antibiotic Resistance Surveillance in Remote Settings , 2015, PloS one.

[31]  D. Fisman,et al.  Core groups, antimicrobial resistance and rebound in gonorrhoea in North America , 2011, Sexually Transmitted Infections.

[32]  Douglas S. Kellogg,et al.  NEISSERIA GONORRHOEAE I , 1963, Journal of bacteriology.

[33]  Wendy Macdowall,et al.  Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours , 2001, The Lancet.

[34]  R. Brunham,et al.  Gonococcal infection, infertility, and population growth: I. Endemic states in behaviourally homogeneous growing populations. , 1992, IMA journal of mathematics applied in medicine and biology.

[35]  M. Unemo,et al.  Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future , 2014, Clinical Microbiology Reviews.

[36]  C. Schofield.  Sexually transmitted disease surveillance. , 1982, British medical journal.

[37]  J. Wallinga,et al.  Public health measures to control the spread of antimicrobial resistance in Neisseria gonorrhoeae in men who have sex with men , 2014, Epidemiology and Infection.

[38]  T. Farley,et al.  Asymptomatic sexually transmitted diseases: the case for screening. , 2003, Preventive medicine.

[39]  Shah Jamal Alam,et al.  Heterogeneity in Number and Type of Sexual Contacts in a Gay Urban Cohort , 2012, Statistical communications in infectious diseases.

[40]  Troy Day,et al.  Aggressive Chemotherapy and the Selection of Drug Resistant Pathogens , 2013, PLoS pathogens.

[41]  M. Unemo,et al.  Antimicrobial Resistance and Molecular Typing of Neisseria gonorrhoeae Isolates in Kyoto and Osaka, Japan, 2010 to 2012: Intensified Surveillance after Identification of the First Strain (H041) with High-Level Ceftriaxone Resistance , 2013, Antimicrobial Agents and Chemotherapy.